ImmuCell Corporation
No trades
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 19.24 M USD, the most of which — 27.45 M USD — came from its top-performing segment, Scours, compared to 26.31 M USD the previous year. The greatest contribution came from United States, which accounted for 24.39 M USD last year, with 22.89 M USD the year before.
By source
By country